The growing role of pediatric intensive care units (PICUs) for managing bronchiolitis in infants and young toddlers over the last decade was associated with increased use of noninvasive respiratory ...

CXCL12 and CXCL13 are potential biomarkers for RSV bronchiolitis severity and recurrence risk, with elevated levels indicating severe cases and recurrent wheezing, respectively. RSV remains a major ...

After a 2022/2023 season marked by a severe epidemic of bronchiolitis due to respiratory syncytial virus (RSV), in particular in terms of emergency department visits and hospital admissions, on ...

Although inhaled epinephrine (adrenaline) has been found to reduce the need for hospitalization when given to patients with bronchiolitis in the emergency department, it is not clear whether ...

Lung diseases in children can affect how comfortably your child breathes, plays, and sleeps, so it is important not to brush ...

A single dose of the long-acting antibody nirsevimab developed to prevent respiratory syncytial virus infections (The drug has been approved at the European level to protect infants in their first ...

Please provide your email address to receive an email when new articles are posted on . Treating bronchiolitis outside the ICU with weight-based high-flow nasal cannula protocols reduced ICU ...

A quarter to half of healthy infants born at term are infected with RSV in the first year of life, and 2-3% have small airway bronchiolitis and lower respiratory tract infection that requires hospital ...

Both the influenza and pneumococcal vaccines are appropriate for patients with asthma. A recent study has also shown that patients with asthma have a higher likelihood of invasive pneumococcal disease ...